Welcome to the first dedicated Endo-ERN training and education newsletter.  There are many educational opportunities that involve network members and provide the opportunity to learn directly from experts in rare endocrine conditions.  

To ensure that you receive this dedicated newsletter which will showcase endorsed events, webinars, relevant national meetings, and congresses please update your preferences following the instructions detailed below.  

Enjoy the read!

Endo-ERN team

REGISTER: Joint Congress of ESPE and ESE 2025, Copenhagen Denmark

The European Society of Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) are joining forces to create a unique joint Congress in 2025.

This very special joint Congress is themed Connecting Endocrinology Across the LIfe Course and will be held 10-13 May, 2025 in Copenhagen, Denmark.

REGISTER: VIIIth ISPAD/VAPES Postgraduate Course and Conference - Diabetes and Rare Disease Course

After the success of the previous ISPAD/VAPES meetings local organizers (Varna Pediatric Endocrine Society, VAPES) aim to attract any interested pediatric endocrinologists, pediatricians, postgraduate trainees, medical students and nurses in 2025.

REGISTER: 24th Advanced Postgraduate Course on Growth and Growth Disorders

This 5-day course will cover the biology of human growth and clinical management of growth disorders. Teachers are internationally recognised experts in paediatric endocrinology and growth.

The course is directed towards clinical fellows and recently graduated pediatric endocrinologists and is limited to 26 participants. 

REGISTER: 5th CAre for PITuitary Adenoma Leiden (CAPITAL) Course

Endo-ERN has endorsed an upcoming course by Endo-ERN HCP, Leiden University Medical Center (LUMC).

5th CAPITAL ? June 5-6, 2025

You are invited to register for the 5th Care for Pituitary Adenomas Leiden (CAPITAL) multidisciplinary workshop in Leiden, the Netherlands.  

VIP REGISTRATION: World Orphan Drug Congress 2025

Endo-ERN is delighted to be a partner of The World Orphan Drug Congress Europe taking place 27-29 October, 2025 in Amsterdam, the Netherlands. Network members are eligible for a complimentary VIP registration for this event.  Find out more.   

CALL: Abstracts for ESPE-OSCAR Science Symposium, 18-19 September, Paris, France

Call for abstracts is now open for the upcoming European Society for Paediatric Endocrinology (ESPE) and French rare riseases healthcare network (OSCAR) being held 18-19 September in Paris France. Late-breaking abstract submission deadline 27 April, 2025, 23:59 CET. Abstract submitters will be notified regarding acceptance/rejection oral/poster by 26 may, 2025.

REGISTER: Upcoming webinars

Endo-ERN experts continue to deliver informative webinars that increases the expertise in the network.  

June:  Novel monitoring tools to detect chronic over- or under treatment in children in CAH 

June:  Rare diease research and the value of registries 

Register now for these upcoming webinars.  Remember if you cannot attend live, register anyway and you will receive a recording.

REGISTER: Additional Conferences and Training Events

Upcoming events that might be of interest to you or your team:

ESE Young Endocrinologists and Scientists (EYES)

16th European Paediatric Neurology Society Congress 

CONTRIBUTE: Committee on Public Health (SANT) launches public consultation on rare diseases

A public consultation is now open seeking information from a range of #rare disease stakeholders. This information will be utilized by the Committee on Public Health (SANT) to bring a better understanding and detailed knowledge of the challenges of persons affected by rare disease and views of persons working with or involved in rare diseases.?

UPDATE: Newsletter Preferences

To update your newsletter preferences go to the top of this newsletter and click on Update Profile.  You can then adjust your preferred topics to ensure that you receive a newsletter that contains information that you are interested in.  This short video shows you how to make the update.